## **Core Concept**
The question tests knowledge of Selective Serotonin Reuptake Inhibitors (SSRIs) and their specific use in treating childhood depression. SSRIs are a class of drugs commonly used to treat depression and anxiety disorders by increasing the levels of serotonin in the brain. The use of SSRIs in children and adolescents is a specific consideration due to the potential for different side effects and efficacy profiles compared to adults.

## **Why the Correct Answer is Right**
Fluoxetine is the correct answer because it is the only SSRI that has been specifically approved by the FDA for the treatment of major depressive disorder in children and adolescents. It works by inhibiting the reuptake of serotonin, thereby increasing its availability in the synaptic cleft and enhancing neurotransmission. This mechanism is thought to contribute to its antidepressant effects.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While sertraline is an SSRI used for depression, it is not specifically approved for use in childhood depression in the same way fluoxetine is. However, it may be prescribed off-label for this purpose.
- **Option B:** Paroxetine is another SSRI, but it is not typically used as a first-line treatment for childhood depression. It has a different side effect profile compared to fluoxetine.
- **Option D:** Citalopram is also an SSRI, but it is not specifically indicated for childhood depression. Escitalopram, its enantiomer, has a slightly different profile but still isn't the first choice for children.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that while fluoxetine is approved for treating depression in children and adolescents, its use, along with other SSRIs in this population, requires careful consideration of potential side effects, such as increased risk of suicidal thoughts and behaviors, especially in the initial treatment period.

## **Correct Answer:** . Fluoxetine